Companies / India
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Glenmark Looks To Chronic Diseases
November 2007 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Possibly encouraged by signs that non-communicable chronic diseases such as diabetes and cancer are on the rise in Africa, Glenmark Pharmaceuticals Nigeria, a subsidiary of India's Glenmark Pharmaceuticals has announced the expansion of its product range. In 2000, almost half the burden of disease was due to non-communicable diseases in low and middle-income countries - a proportion that is set to rise over the coming years as infectious disease control is improved and Western lifestyles become more